Image de couverture de livre

In-depth proteomic characterization of the response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using data-independent acquisition mass spectrometry (DIA-MS)

Fuente: Zenodo

Enregistré dans:

Détails bibliographiques
Auteur principal:	Cavic, Milena
Format:	Recurso digital
Publié:	Zenodo 2022
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Differential effects of RAS mutations on chemoradiotherapy and total neoadjuvant therapy in locally advanced rectal cancer
par: Erina Haraguchi, et autres
Publié: (2025)

Lymph node regression after neoadjuvant chemoradiotherapy in rectal cancer
par: Sonay K Ozturk, et autres
Publié: (2024)

MRI‐based qualitative, quantitative, and radiomics/deep learning methods for assessing treatment response after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
par: Shuang Chen, et autres
Publié: (2026)

A crustacean neuropeptide spectral library for data‐independent acquisition (DIA) mass spectrometry applications
par: Lauren Fields, et autres
Publié: (2024)

Phase II study of long‐course chemoradiotherapy followed by consolidation chemotherapy as total neoadjuvant therapy in locally advanced rectal cancer in Japan: ENSEMBLE‐2
par: Yoshinori Kagawa, et autres
Publié: (2024)

Comparative proteomics analysis of female fibromyalgia and osteoarthritis using data‐independent acquisition sequential window acquisition of all theoretical mass spectra‐based mass spectrometry
par: Cheng‐Yu Kuo, et autres
Publié: (2024)

Magnetic resonance imaging‐based radiomics analysis for prediction of treatment response to neoadjuvant chemoradiotherapy and clinical outcome in patients with locally advanced rectal cancer: A large multicentric and validated study
par: TingDan Hu, et autres
Publié: (2024)

Comparing local excision with watch and wait for the management of rectal cancer patients responding to neoadjuvant chemoradiotherapy: Composite endpoint analysis using the win ratio
par: Giulia Capelli, et autres
Publié: (2025)

Gross morphologic features of surgical specimen in rectal cancer patients with pathological complete response following neoadjuvant chemoradiotherapy: A cross‐sectional study
par: Amir Reza Fazeli, et autres
Publié: (2024)

Active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer
par: Mary Beth Nierengarten
Publié: (2025)

Comparing outcomes and cost in surgery versus watch & wait surveillance of patients with rectal cancer post neoadjuvant long course chemoradiotherapy
par: Rory Crean, et autres
Publié: (2024)

Transformer-based de novo peptide sequencing for data-independent acquisition mass spectrometry
par: Ebrahimi, Shiva, et autres
Publié: (2024)

Predictive value of circulating lymphocyte subsets and inflammatory indexes for neoadjuvant chemoradiotherapy response in rectal mucinous adenocarcinoma patients: A machine learning approach
par: Yu Lin, et autres
Publié: (2024)

MRI‐based parameters and clinical risk factors to predict lymph node metastasis in patients with ypT0 rectal cancer after neoadjuvant chemoradiotherapy
par: Yangyang Wang, et autres
Publié: (2024)

The conundrum of total neoadjuvant therapy in rectal cancer
par: Devesh S. Ballal, et autres
Publié: (2024)

Total neoadjuvant therapy with six versus four cycles of CAPOX in locally advanced rectal cancer: A real‐world study
par: Yan‐qin Lan, et autres
Publié: (2025)

Neoadjuvant chemoimmunotherapy was associated with better short‐term survival of patients with locally advanced esophageal squamous cell carcinoma compared to neoadjuvant chemoradiotherapy
par: Xiaofeng Duan, et autres
Publié: (2024)

Foundation model for mass spectrometry proteomics
par: Sanders, Justin, et autres
Publié: (2025)

Nomogram for predicting pathologic complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
par: Guihong Liu, et autres
Publié: (2024)

Circulating genomic biomarkers predict chemoradiotherapy resistance and immunotherapy response in locally advanced non‐small‐cell lung cancer
par: Yu Wang, et autres
Publié: (2025)

Improved breast milk proteome coverage by DIA based LC‐MS/MS method
par: Jenni Viitaharju, et autres
Publié: (2024)

Nonoperative management protocol for locally advanced rectal cancer
par: Erin D. Kennedy, et autres
Publié: (2024)

Contemporary neoadjuvant strategies for rectal cancer: The GRECCAR snapshot study
par: Antoine Cazelles, et autres
Publié: (2026)

Narrative review of neoadjuvant therapy in patients with locally advanced colon cancer
par: Jen‐Pin Chuang, et autres
Publié: (2024)

Histological and photoacoustic evaluation of rectal cancer after neoadjuvant therapy using microvascular density
par: Ahmed A. Eltahir, et autres
Publié: (2024)

Outcomes of rectal cancer patients who refuse surgery after incomplete clinical response to neoadjuvant therapy
par: Kevin P. Labadie, et autres
Publié: (2024)

Rectal adenocarcinoma: Ex vivo 9.4T MRI—correlation with histopathologic treatment response to neoadjuvant chemoradiotherapy
par: Zhihui Li, et autres
Publié: (2024)

Screening of novel biomarkers for acute kidney transplant rejection using DIA‐MS based proteomics
par: Ce Wang, et autres
Publié: (2024)

Impact of neoadjuvant immunotherapy on postoperative complications after surgery for rectal cancer
par: Matthew Shou, et autres
Publié: (2024)

Acellular mucin pools and neutrophil‐to‐lymphocyte ratio: unveiling hidden aggressiveness in pathological complete response after chemoradiotherapy for rectal cancer
par: Zhenyu Xu, et autres
Publié: (2025)

Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer
par: Klara Hammarström, et autres
Publié: (2024)

Overall survival benefit of pembrolizumab plus chemoradiotherapy for patients with high‐risk locally advanced cervical cancer
par: Mary Beth Nierengarten
Publié: (2025)

Evolution of genome and immunogenome in esophageal squamous cell carcinomas driven by neoadjuvant chemoradiotherapy
par: Zelin Weng, et autres
Publié: (2024)

The use of sequential window acquisition of all theoretical fragment ion spectra (SWATH), a data‐independent acquisition high‐resolution mass spectrometry approach, in forensic toxicological regimes: A review
par: Maria Sarkisian, et autres
Publié: (2024)

Therapeutic impact of neoadjuvant chemotherapy on lymph node metastasis in locally advanced cervical cancer
par: Yuka Mizuta, et autres
Publié: (2025)

Oxaliplatin‐induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose–response relationship and impact on quality of life
par: Georg W. Wurschi, et autres
Publié: (2026)

Vessel skeletonization in lateral pelvic lymph node dissection for male and female patients with anomalous anatomy following neoadjuvant treatment for locally advanced rectal cancer – A video vignette
par: Georgios Karagiannidis, et autres
Publié: (2024)

Discovery of cerebrospinal fluid biomarkers for different dementias using mass spectrometry‐based proteomics
par: Marijke E. Stokkel, et autres
Publié: (2026)

Impact of neoadjuvant therapy on nodal harvest in clinical stage III rectal cancer: Establishing optimum cut‐offs by disease response
par: Chase J. Wehrle, et autres
Publié: (2024)

Mass spectrometry‐based mitochondrial proteomics for cancer biomarker discovery
par: Zheng Cao, et autres
Publié: (2026)